ScholarWorks@Hanyang University

Browsing by Won, Jong ChulAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUS
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozinGo to Link

Lim, Soo; Lee, Seung-Hwan; Min, Kyung-Wan; Lee, Chang Beom; Kim, Sang Yong; Yoo, Hye Jin; Kim, Nan Hee; Kim, Jae Hyeon; Oh, Seungjoon; Won, Jong Chul, et al.

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.6, pp 2188 - 2198PublisherBlackwell Publishing Inc.
SCIESCOPUSKCI
Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current StatusGo to Linkopen access

Kim, Bo-Yeon; Won, Jong Chul; Lee, Jae Hyuk; Kim, Hun-Sung; Park, Jung Hwan; Ha, Kyoung Hwa; Won, Kyu Chang; Kim, Dae Jung; Park, Kyong Soo

ArticleIssue Date2019CitationDIABETES & METABOLISM JOURNAL, v.43, no.4, pp 487 - 494PublisherKOREAN DIABETES ASSOC
SCIESCOPUS
Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational StudyGo to Linkopen access

Hong, Jun Hwa; Yu, Sung Hoon; Baek, Ki-hyun; Yu, Jaemyung; Lee, Seung Jin; Kim, Hyung-wook; Park, Kang Seo; Kim, Jung Han; Min, Kyungwan; Lee, Yong Hwan, et al.

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.5, pp 4112 - 4120PublisherWILEY
SCIESCOPUS
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III studyGo to Linkopen access

Hong, Jun Hwa; Kim, Myung Jin; Min, Kyung Wan; Won, Jong Chul; Kim, Tae Nyun; Lee, Byung-Wan; Kang, Jun Goo; Kim, Jae Hyeon; Park, Jung Hwan; Ku, Bon Jeong, et al.

ArticleIssue Date2025CitationDIABETES OBESITY & METABOLISM, v.27, no.1, pp 81 - 91PublisherWILEY
SCIESCOPUSKCI
Efficacy and Safety of High-Dose Pioglitazone as Addon Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled TrialGo to Linkopen access

Hong, Jun Hwa; Han, Kyung Ah; Hwang, You-Cheol; Hong, Eun-Gyoung; Kim, Hae Jin; Lee, Chang Beom; Cho, Ho Chan; Won, Jong Chul; Kim, Hun-Sung; Kim, Eui-Hyun, et al.

ArticleIssue Date2026CitationDIABETES & METABOLISM JOURNAL, v.50, no.2, pp 321 - 330PublisherKOREAN DIABETES ASSOC
SCIESCOPUS
Efficacy and Safety of Sarpogrelate on Symptom Improvement in Patients with Peripheral Arterial Disease (PAD) and/or Being at Risk of PAD: A Single Arm, Multi-Centered, Open-Label TrialGo to Link

Won, Jong Chul; Song, Tae-Jin; Park, Jae Hyoung; Kim, Hee-Tae; Lee, Kyong Hoon; Park, Keun Yong; Jeong, Ho-Seung; Jeon, Ung; Min, Kyung Wan; Lim, Soo

ArticleIssue Date2025CitationCurrent Vascular Pharmacology, v.23, no.1, pp 45 - 56PublisherBentham Science Publishers
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어